Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) / Multiple Myeloma (MM) Among Unique Populations of Black People (MAGIC)
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
This study is being done to screen for monoclonal gammopathies in people of East African descent. Monoclonal gammopathy is a condition where abnormal proteins are found in the blood, most commonly called monoclonal gammopathy of undetermined significance or MGUS. There is little information on the presence of this condition in people of East African descent. This study is being done to determine how this condition affects this population in order to better treat and/or prevent this condition in the future.
Full description
PRIMARY OBJECTIVE:
I. To determine the prevalence of monoclonal gammopathies (MGUS, Smoldering and Multiple Myeloma) in people of East African descent in Minnesota.
OUTLINE: This is an observational study.
Participants undergo medical chart review and blood sample collection, as well as complete a questionnaire on study. Participants who test positive for MGUS are notified, along with their primary care physician, so that the necessary follow up and referral is provided as clinically indicated.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Adults ≥ 40 years
- Self-reported east African ancestry (including individuals of mixed east African descent)
- Willing and able to review, understand, and provide consent before starting any study-specific procedures
Exclusion criteria
- Pregnant women
Trial design
1,000 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal